Advertisement

Topics

Partnership begins clinical trials for anti-malaria drug

05:23 EDT 22 Aug 2017 | SmartBrief

Novartis and Medicines for Malaria Venture are testing KAF156, a new compound that, in combination with lumefantrine, has the -More

Original Article: Partnership begins clinical trials for anti-malaria drug

NEXT ARTICLE

More From BioPortfolio on "Partnership begins clinical trials for anti-malaria drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Malaria
Malaria is a serious tropical disease spread by mosquitoes. If malaria is not diagnosed and treated promptly, it can be fatal. What causes malaria? Malaria is caused by a type of parasite known as Plasmodium. There are many different types of Plasmod...